Skip to Main Content

Paper Details

Early Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer.
J Clin Oncol
4
2023
ARASENS, Metastatic Hormone-Sensitive Prostate Cancer, androgen, androgen-receptor, darolutamide, docetaxel, mHSPC, metastatic hormone-sensitive prostate cancer, patients
Author NameAffiliation
Jeremiah WalaDana-Farber Cancer Institute
Jeremiah WalaDana-Farber Cancer Institute
Paul L NguyenDana-Farber Cancer Institute
Mark M PomerantzDana-Farber Cancer Institute
Mark M PomerantzDana-Farber Cancer Institute
  • 1 - 5

Datasets

Release 1.2